Virtual Media Briefing: A vaccine for all coronaviruses

Duke researchers have created a vaccine with the potential to protect against all forms of coronavirus that move from animals to humans, now and in the future.

The vaccine works by attacking a genetic sequence common to all forms of coronavirus that enables them to bind to human cells. The new vaccine has been 100 percent effective in non-human tests.

Two Duke immunologists will discuss their research and its implications during a video conference call for the media also available for general viewing on YouTube.

Faculty Participants

Dr. Bart Haynes
Dr. Bart Haynes is a professor of medicine and immunology at the Duke School of Medicine and director of the Duke Human Vaccine Institute. His research focuses on immunology, retrovirology and HIV vaccine development.

Kevin Saunders
Kevin Saunders is an associate professor of surgery at the Duke University School of Medicine. He is also director of research at the Duke Human Vaccine Institute, where he oversees the design of he oversees the design of proteins used in vaccines.